Immunotherapy Cancer Treatment
-
{
- All
- News
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
- Tuesday April 14, 2026
- Health | Written by Tanushka Dutta
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
www.ndtv.com
-
Chemotherapy Vs Immunotherapy: What's The Difference In Cancer Care?
- Tuesday April 14, 2026
- Health | Written by Sambhav Kumar
Immunotherapy is generally associated with fewer and milder side effects compared to chemotherapy. Many patients are able to continue their routine activities during treatment.
-
www.ndtv.com
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
- Tuesday April 14, 2026
- Health | Written by Debosmita Ghosh
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
- Monday April 13, 2026
- Health | Written by Debosmita Ghosh
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
From Surgery To Immunotherapy: Doctor Explains Advances In Oral Cancer Treatment
- Friday April 3, 2026
- Health | Written by Sambhav Kumar
A major shift in recent years is the use of immunotherapy earlier in the treatment process, even before surgery. This is known as neoadjuvant immunotherapy.
-
www.ndtv.com
-
When Stomach Pain Isn't Just Acidity: The Red Flags In Dipika Kakar's Recent Diagnosis
- Monday February 23, 2026
- Health | Written by Rupashi Chhabra
Television actress Dipika Kakar's recent stomach pain revealed a 13 mm cyst after her liver cancer treatment. Here are the red flags that show stomach pain can be more than acidity, and why you need to be aware of it.
-
www.ndtv.com
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
- Tuesday February 10, 2026
- Health | Indo-Asian News Service
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
www.ndtv.com
-
Lung Cancer: Australian Scientists Map Cancer Cells To Predict Treatment Response
- Wednesday February 4, 2026
- Health | Indo-Asian News Service
Scientists in Australia have mapped the "neighbourhoods" of lung cancer cells and found that cell metabolism plays a key role in determining how patients respond to immunotherapy.
-
www.ndtv.com
-
Union Budget 2026: 17 Cancer Drugs Get Import Duty Exemption To Cut Costs And Save Lives
- Monday February 2, 2026
- Health | Written by Shreya Goswami
The Union Budget 2026-27 has exempted basic customs duty on 17 critical cancer drugs to reduce treatment costs and improve access for patients reliant on expensive imported medicines.
-
www.ndtv.com
-
South Korea Develops AI Model For A Custom Cancer Vaccine
- Friday January 2, 2026
- Health | Indo-Asian News Service
A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm Neogenlogic have developed a new artificial intelligence.
-
www.ndtv.com
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
- Tuesday April 14, 2026
- Health | Written by Tanushka Dutta
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
www.ndtv.com
-
Chemotherapy Vs Immunotherapy: What's The Difference In Cancer Care?
- Tuesday April 14, 2026
- Health | Written by Sambhav Kumar
Immunotherapy is generally associated with fewer and milder side effects compared to chemotherapy. Many patients are able to continue their routine activities during treatment.
-
www.ndtv.com
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
- Tuesday April 14, 2026
- Health | Written by Debosmita Ghosh
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
- Monday April 13, 2026
- Health | Written by Debosmita Ghosh
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
From Surgery To Immunotherapy: Doctor Explains Advances In Oral Cancer Treatment
- Friday April 3, 2026
- Health | Written by Sambhav Kumar
A major shift in recent years is the use of immunotherapy earlier in the treatment process, even before surgery. This is known as neoadjuvant immunotherapy.
-
www.ndtv.com
-
When Stomach Pain Isn't Just Acidity: The Red Flags In Dipika Kakar's Recent Diagnosis
- Monday February 23, 2026
- Health | Written by Rupashi Chhabra
Television actress Dipika Kakar's recent stomach pain revealed a 13 mm cyst after her liver cancer treatment. Here are the red flags that show stomach pain can be more than acidity, and why you need to be aware of it.
-
www.ndtv.com
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
- Tuesday February 10, 2026
- Health | Indo-Asian News Service
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
www.ndtv.com
-
Lung Cancer: Australian Scientists Map Cancer Cells To Predict Treatment Response
- Wednesday February 4, 2026
- Health | Indo-Asian News Service
Scientists in Australia have mapped the "neighbourhoods" of lung cancer cells and found that cell metabolism plays a key role in determining how patients respond to immunotherapy.
-
www.ndtv.com
-
Union Budget 2026: 17 Cancer Drugs Get Import Duty Exemption To Cut Costs And Save Lives
- Monday February 2, 2026
- Health | Written by Shreya Goswami
The Union Budget 2026-27 has exempted basic customs duty on 17 critical cancer drugs to reduce treatment costs and improve access for patients reliant on expensive imported medicines.
-
www.ndtv.com
-
South Korea Develops AI Model For A Custom Cancer Vaccine
- Friday January 2, 2026
- Health | Indo-Asian News Service
A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm Neogenlogic have developed a new artificial intelligence.
-
www.ndtv.com